Molecular endotypes of type 1 and type 2 SLE

Robert Robl, Amanda Eudy, Prathyusha S Bachali, Jennifer L Rogers, Megan Clowse, David Pisetsky, Peter Lipsky

10.1136/lupus-2022-000861

January 30, 2023

Urinary markers differentially associate with kidney inflammatory activity and chronicity measures in patients with lupus nephritis

Ahmad Akhgar, Dominic Sinibaldi, Lingmin Zeng, Alton B Farris III, Jason Cobb, Monica Battle, David Chain, Jennifer A Cann, Gábor G Illei, S Sam Lim, Wendy I White

10.1136/lupus-2022-000747

January 30, 2023

Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus

Serena Fasano, Valentina Messiniti, Michele Iudici, Melania Alessia Coscia, Francesco Ciccia

10.1136/lupus-2022-000841

January 11, 2023

Clinical outcome in patients with suspected inflammatory neuropsychiatric lupus treated with immunosuppression: an observational cohort study

Rory C Monahan, Liesbeth J J Beaart-van de Voorde, Rolf Fronczek, Jeroen de Bresser, Jeroen Eikenboom, Margreet Kloppenburg, Huub A M Middelkoop, Gisela M Terwindt, Nic J A van der Wee, Tom W J Huizinga, Gerda M Steup-Beekman

10.1136/lupus-2022-000850

February 3, 2023

Meeting report: the ALPHA project: a stakeholder meeting on lupus clinical trial outcome measures and the patient perspective

Joy Buie, Lauren Bloch, Eric F Morand, Ronald F van Vollenhoven, Victoria P Werth, Zahi Touma, Peter Lipsky, Kenneth Kalunian, Anca D Askanase, L Ines, Christopher Reed, MaryBeth Son, Timothy Franson, Karen Costenbader, Laura Eve Schanberg

10.1136/lupus-2023-000901

February 14, 2023

Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria

Ronald van Vollenhoven, Anca D Askanase, Andrew S Bomback, Ian N Bruce, Angela Carroll, Maria Dall'Era, Mark Daniels, Roger A Levy, Andreas Schwarting, Holly A Quasny, Murray B Urowitz, Ming-Hui Zhao, Richard Furie

10.1136/lupus-2021-000634

March 28, 2022

Risks of mortality and severe coronavirus disease 19 (COVID-19) outcomes in patients with or without systemic lupus erythematosus

Sebastian Bruera, Xiudong Lei, Hui Zhao, Jinoos Yazdany, Mariana Chavez-MacGregor, Sharon H Giordano, Maria E Suarez-Almazor

10.1136/lupus-2022-000750

February 14, 2023

Time to onset of clinical response to anifrolumab in patients with SLE: pooled data from the phase III TULIP-1 and TULIP-2 trials

Ian N Bruce, Ronald F van Vollenhoven, Konstantina Psachoulia, Catharina Lindholm, Emmanuelle Maho, Raj Tummala

10.1136/lupus-2022-000761

January 13, 2023

Infertility in systemic lupus erythematosus: what rheumatologists need to know in a new age of assisted reproductive technology

Bessie Stamm, Medha Barbhaiya, Caroline Siegel, Sarah Lieber, Michael Lockshin, Lisa Sammaritano

10.1136/lupus-2022-000840

December 13, 2022

A better self-efficacy is predictive of better health-related quality of life (HRQoL) in patients with systemic lupus erythematosus: data from the Almenara Lupus Cohort

Manuel Francisco Ugarte-Gil, Rocio Violeta Gamboa-Cardenas, Cristina Reátegui-Sokolova, Victor Román Pimentel-Quiroz, Mariela Medina, Claudia Elera-Fitzcarrald, Zoila Rodriguez-Bellido, Cesar Augusto Pastor-Asurza, Risto Alfredo Perich-Campos, Graciela S Alarcón

10.1136/lupus-2022-000874

February 14, 2023

Most Read Articles